Abd-Allah Shamel A, Rogers Mark S, Terry Michael, Gross Matthew, Perkin Ronald M
Pediatric Critical Care Division and Respiratory Care Department, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Pediatr Crit Care Med. 2003 Jul;4(3):353-7. doi: 10.1097/01.PCC.0000074267.11280.78.
To illustrate the use of helium-oxygen gas mixtures as therapy for pediatric patients with acute severe asthma requiring conventional mechanical ventilation.
Retrospective review.
Tertiary care children's teaching hospital.
All mechanically ventilated patients with severe asthma admitted to the pediatric intensive care unit from August 1994 to October 2000.
Within 24 hrs of intubation or admission, patients were stabilized on volume ventilation, bronchodilator therapy, corticosteroids, and antibiotics when indicated. Hypercapnia was permitted while maintaining arterial blood gas pH > or =7.25. A helium-oxygen gas mixture then was begun with helium flow set at 5-7 L/min, and oxygen flow was titrated to maintain desired oxygen saturation. Only sedated, chemically paralyzed patients with adequate pre-helium-oxygen and post-helium-oxygen measurements were statistically analyzed.
Twenty-eight mechanically ventilated patients with severe asthma placed on helium-oxygen gas mixtures were identified who met study entry criteria. Mean patient age was 8.8 yrs (range, 1.1-14.6). Before helium-oxygen therapy began, mean peak inspiratory pressure was 40.5 +/- 4.2 cm H(2)O, mean arterial blood gas pH was 7.26 +/- 0.05, and mean CO(2) partial pressure was 58.2 +/- 8.5 torr. After patients were placed on helium-oxygen therapy, there was a significant decrease in mean peak inspiratory pressure to 35.3 +/- 3.0 cm H(2)O. Mean pH increased significantly to 7.32 +/- 0.06, and mean partial pressure CO(2) decreased significantly to 50.5 +/- 7.4 torr. Initial mean inspired helium was 57 +/- 4% (range, 32-74). Mechanical ventilation days ranged from 1 to 23 days (mean, 5.0). Hospital stay ranged from 4 to 29 days (mean, 10.1), with an average pediatric intensive care unit stay of 6.9 days (range, 2-24). There were two incidences of pneumothorax.
In the pediatric patient with severe asthma requiring conventional mechanical ventilation, helium-oxygen administration appears to be a safe therapy and may assist in lowering peak inspiratory pressure and improving blood gas pH and partial pressure CO(2).
阐述氦氧混合气体在需要常规机械通气的急性重症哮喘儿科患者治疗中的应用。
回顾性研究。
三级医疗儿童教学医院。
1994年8月至2000年10月入住儿科重症监护病房的所有机械通气重症哮喘患者。
在插管或入院后24小时内,患者在容量通气、支气管扩张剂治疗、糖皮质激素治疗以及必要时使用抗生素治疗下实现病情稳定。允许出现高碳酸血症,同时维持动脉血气pH值≥7.25。然后开始使用氦氧混合气体,将氦气流量设定为5 - 7升/分钟,并滴定氧气流量以维持所需的氧饱和度。仅对在使用氦氧混合气体前后有充分测量数据的镇静、化学麻痹患者进行统计学分析。
确定了28例接受氦氧混合气体治疗且符合研究纳入标准的机械通气重症哮喘患者。患者平均年龄为8.8岁(范围1.1 - 14.6岁)。在开始氦氧治疗前,平均吸气峰压为40.5±4.2厘米水柱,平均动脉血气pH值为7.26±0.05,平均二氧化碳分压为58.2±8.5托。患者接受氦氧治疗后,平均吸气峰压显著降至35.3±3.0厘米水柱。平均pH值显著升至7.32±0.06,平均二氧化碳分压显著降至50.5±7.4托。初始平均吸入氦气比例为57±4%(范围32 - 74)。机械通气天数为1至23天(平均5.0天)。住院时间为4至29天(平均10.1天),儿科重症监护病房平均住院时间为6.9天(范围2 - 24天)。发生了两例气胸。
对于需要常规机械通气的重症哮喘儿科患者,给予氦氧混合气体似乎是一种安全的治疗方法,可能有助于降低吸气峰压,改善血气pH值和二氧化碳分压。